Mei Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mei Yuan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Danlian Zhou
Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China
1 shared publication - Jing Xu
Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China; Central Laboratory, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China
1 shared publication Peijun Song
Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China
1 shared publication- Qiu Liang
Department of Plastic Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou City 225000, Jiangsu Province, China
1 shared publication - Weiwei Chu
Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China
1 shared publication - Xiuyu Ge
Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Stem Cells International
- Vol. 2025 (1) , 6344844
Adipose‐Derived Stem Cell Exosomes Promote Scar‐Free Healing of Diabetic Wounds via miR‐204‐5p/TGF‐ β 1/Smad Pathway
Numerous researches have demonstrated the therapeutic potential of adipose‐derived stem cell exosomes (ADSC‐Exos) in promoting wound healing. In this study, we aimed to investigate the impact of ADSC‐Exos on diabetic wound fibroblasts and elucidate its possible mechanisms. CCK‐8, Edu, cell scratch, and Transwell tests were used to evaluate the function of ADSC‐Exos on rat skin fibroblasts (RSFs) in high‐glucose (HG) medium. The targeting effect of ADSC‐Exo‐derived microRNA (miRNA) and TGF‐ β 1 was assessed using bioinformatic analysis and then confirmed with western blot and dual luciferase reporter assays. ADSC‐Exos, miR‐204‐5p mimic, and anti‐miR‐204‐5p mimic were used to stimulate RSFs, and the levels of TGF‐ β 1/Smad pathway were analyzed by western blot. In vivo, digital photo and tissue section staining were used to evaluate the therapeutic effect of ADSC‐Exos on diabetic wounds. The data showed that ADSC‐Exos enhance the proliferation and migration of fibroblasts under HG conditions, reduce excessive myofibroblast differentiation and collagen deposition, and promote scarless healing of diabetic wounds. Additionally, miR‐204‐5p in ADSC‐Exos targets TGF‐ β 1 to inhibit p‐Smad2/3, Col I, and alpha‐smooth muscle actin ( α ‐SMA), thereby reducing fibrosis. These findings suggest that ADSC‐Exos have potential prospects for promoting diabetic wound healing.
- 1 January 2025
- Published by Wiley in Stem Cells International
- Vol. 2025 (1) , 6344844
Open AccessAdipose‐Derived Stem Cell Exosomes Promote Scar‐Free Healing of Diabetic Wounds via miR‐204‐5p/TGF‐ β 1/Smad Pathway
Numerous researches have demonstrated the therapeutic potential of adipose‐derived stem cell exosomes (ADSC‐Exos) in promoting wound healing. In this study, we aimed to investigate the impact of ADSC‐Exos on diabetic wound fibroblasts and elucidate its possible mechanisms. CCK‐8, Edu, cell scratch, and Transwell tests were used to evaluate the function of ADSC‐Exos on rat skin fibroblasts (RSFs) in high‐glucose (HG) medium. The targeting effect of ADSC‐Exo‐derived microRNA (miRNA) and TGF‐ β 1 was assessed using bioinformatic analysis and then confirmed with western blot and dual luciferase reporter assays. ADSC‐Exos, miR‐204‐5p mimic, and anti‐miR‐204‐5p mimic were used to stimulate RSFs, and the levels of TGF‐ β 1/Smad pathway were analyzed by western blot. In vivo, digital photo and tissue section staining were used to evaluate the therapeutic effect of ADSC‐Exos on diabetic wounds. The data showed that ADSC‐Exos enhance the proliferation and migration of fibroblasts under HG conditions, reduce excessive myofibroblast differentiation and collagen deposition, and promote scarless healing of diabetic wounds. Additionally, miR‐204‐5p in ADSC‐Exos targets TGF‐ β 1 to inhibit p‐Smad2/3, Col I, and alpha‐smooth muscle actin ( α ‐SMA), thereby reducing fibrosis. These findings suggest that ADSC‐Exos have potential prospects for promoting diabetic wound healing.